Faculty Director Gary Marchant spoke at the World Health Organization’s Experty Advisory Committee last month in Switzerland. The committee aimed to develop global standards for governance of human genome editing.
This committee meeting comes after the controversial decisions of various scientists to apply gene editing to humans without any proper guidelines or governance set in place.
Marchant’s presentation argued for the use of “soft law” mechanisms to advance international coordination of CRISPR gene editing governance.
Share on facebook
Share on email
Share on twitter
Share on linkedin